Science

Mario Balsa/X

Jul 7, 2025, 23:42

Mario Balsa: A Must-read For Residents

Mario Balsa, Medical Oncology Resident at Catalan Institute of Oncology (ICO), shared a post on X:

“A must-read for residents!

A timely review in Frontiers – Immunology dives into antibody-based strategies for HCC.

ICIs (PD-1/L1, CTLA-4), bispecifics, ADCs
Explores mechanisms: immune modulation, angiogenesis inhibition, cytotoxicity
Key challenges: heterogeneity, resistance, irAEs

When it comes to HCC, antibody therapies aren’t just promising — they’re raising the bar(y)er.”

Title: Antibody treatment of hepatocellular carcinoma: a review of current and emerging approaches

Authors: Sherif A. El-Kafrawy, Mostafa S. Elkafrawy, Esam I. Azhar, Anwaar Saeed, Ashraf A. Tabll

Read the Full Article on Frontiers – Immunology

Mario Balsa: A Must-read For Residents

More posts featuring Mario Balsa.

Anwaar Saeed Ashraf A. Tabll cancer Esam I. Azhar HCC hepatocellular carcinoma Mario Balsa Mostafa S. Elkafrawy OncoDaily Oncology Sherif A. El-Kafrawy

25 Posts Not To Miss From ESMO GI 2025

Botensilimab and Balstilimab Show Durable Survival in MSS Colorectal Cancer: ESMO GI 2025 Update

Julian McMahon Dies at 56: A Look Back at His Private Cancer Battle and Legendary Acting Career

Vivek Subbiah: It’s Time We Evolve WHO Cancer Classification

ESMO 50th Anniversary: Half a Century of Evidence-Based Cancer Care